Depression Screening Tools for Patients with Kidney Failure: A Systematic Review.

Clinical Journal of the American Society of Nephrology : CJASN
Karli KondoPavan Chopra

Abstract

Patients with kidney failure experience depression at rates higher than the general population. Despite the Centers for Medicare and Medicaid Services' ESRD Quality Incentive Program requirements for routine depression screening for patients with kidney failure, no clear guidance exists. For this systematic review, we searched MEDLINE, PsycINFO, and other databases from inception to June 2020. Two investigators screened all abstracts and full text. We included studies assessing patients with kidney failure and compared a tool to a clinical interview or another validated tool (e.g., Beck Depression Inventory II). We abstracted data related to sensitivity and specificity, positive and negative predictive value, and the area under the curve. We evaluated the risk of bias using the Quality Assessment of Diagnostic Accuracy Studies 2. A total of 16 studies evaluated the performance characteristics of depression assessment tools for patients with kidney failure. The Beck Depression Inventory II was by far the best studied. A wide range of thresholds were reported. Shorter tools in the public domain such as the Patient Health Questionnaire 9 and Geriatric Depression Scale 15 (adults over 60) performed well but were not well studied. S...Continue Reading

References

Jan 1, 1990·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·C R SacksP L Kimmel
Feb 1, 1986·British Medical Journal·R P Snaith, A S Zigmond
Dec 1, 1967·The British Journal of Social and Clinical Psychology·M Hamilton
Jan 1, 1982·Journal of Psychiatric Research·J A YesavageV O Leirer
Sep 15, 2001·Journal of General Internal Medicine·K KroenkeJ B Williams
Jan 22, 2005·Journal of the American Society of Nephrology : JASN·Manjula KurellaGlenn M Chertow
Oct 29, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Suzanne WatnickLinda Ganzini
Mar 8, 2008·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Joseph ChilcotKen Farrington
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
Dec 15, 2010·Nephron. Clinical Practice·Rasheed A BalogunEmaad M Abdel-Rahman
Aug 11, 2012·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Tessa O van den BeukelAdriaan Honig
Nov 5, 2013·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Farhat FarrokhiSarbjit Vanita Jassal
Aug 2, 2014·Clinical Journal of the American Society of Nephrology : CJASN·Steven D WeisbordMichael J Fine
Jan 28, 2016·JAMA : the Journal of the American Medical Association·Albert L SiuMichael P Pignone
Mar 24, 2016·Journal of Clinical Epidemiology·Jessie McGowanCarol Lefebvre
Sep 22, 2018·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Yun-Yan WangYa-Ni He
Feb 6, 2019·Canadian Journal of Kidney Health and Disease·David CollisterMichael Walsh

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.